Calc Function

    • Calcs that help predict probability of a diseaseDiagnosis
    • Subcategory of 'Diagnosis' designed to be very sensitiveRule Out
    • Disease is diagnosed: prognosticate to guide treatmentPrognosis
    • Numerical inputs and outputsFormula
    • Med treatment and moreTreatment
    • Suggested protocolsAlgorithm

    Disease

    Select...

    Specialty

    Select...

    Chief Complaint

    Select...

    Organ System

    Select...

    Patent Pending

    SSIGN Score for Renal Cell Carcinoma (RCC)

    Predicts progression of clear cell renal cell carcinoma after radical nephrectomy.
    Favorite
    Pearls/Pitfalls
    • The SSIGN (Stage, Size, Grade and Necrosis) score applies to clear cell renal cell carcinoma (RCC) at all stages, but not to other types of RCC.
    • Validated in multiple patient cohorts.

    Result:

    Please fill out required fields.

    Next Steps
    Evidence
    Creator Insights

    Advice

    Some experts believe this score should not be used as a single prognostic system in all histologic subgroups. Consider other prognostic systems.

    Dr. Igor Frank

    About the Creator

    Igor Frank, MD, is a professor of urology at the Mayo Clinic in Rochester, MN. Currently, he is the head of the Mayo Clinic bladder removal (cystectomy) registry. His research focuses mainly on treatment and prognosis of survival in bladder and prostate cancer, though he also researches continuity and quality of care for cancer patients.

    To view Dr. Igor Frank's publications, visit PubMed